Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 29. September 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9089  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 181776  
   
Primary renal glomus tumours of uncertain malignant potential: diagnostic challenges and insights from two instances.
BMJ Case Rep
Sharma B, Jose CE, Yesodharan J, Mangalath Rajamma B.
PMID: 42805617 [PubMed - indexed for MEDLINE]


Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes in Non-metastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys
Lichtman-Mikol S, Attia SK, Sun Y, Malone S, Grimes S, Kishan AU, Zaorsky NG, Spratt DE, Morgan SC, Jia AY, Roy S.
PMID: 42805409 [PubMed - as supplied by publisher]


Diagnostic performance of 29-MHz micro-ultrasound using cognitive fusion with multiparametric MRI for the detection of clinically significant prostate cancer: a single-center retrospective study.
Fr J Urol
Idri C, Michel F, Soulie M, Thoulouzan M, Doumerc N, Roumiguie M, Brierre T, Game X, Bajeot AS.
PMID: 42805393 [PubMed - as supplied by publisher]


Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.
JCO Oncol Pract
Guha A, Barac A, Ryan MJ, Hamdan R, Devgan G, Marshall CH, Gillessen S, Loeb S, McKay RR, Antonarakis ES, Klaassen Z, Davuluri M, Bryce AH, Li YR, El-Chaar N, Braun S, Hussain M, Barata P, Schoen MW, Sternberg CN, Jamaspishvili T, Washington SL 3rd, Shore ND, Morris D, Andrews JR, Riaz IB, George D, Roy S, Carithers GB, Koo P, Agarwal N, Hahn AW.
PMID: 42804714 [PubMed - as supplied by publisher]


Solid Malignant Tumors in Infancy: A Single-Center Experience.
J Pediatr Hematol Oncol
Kanbur ÖD, Kurucu N, Susam , Aydin GB, Yalç, Varan A, Kutluk T.
PMID: 42804586 [PubMed - indexed for MEDLINE]


Adrenal Rest Tumors and the clinical course of gonadal dysfunction in adult men with Congenital Adrenal Hyperplasia caused by 21-Hydroxylase Deficiency: A single-center experience with long-term follow-up.
Endocrine
Ozturk Unsal I, Koray Fedai N, Hepsen S, Ucan B, Ozbek M, Cakal E.
PMID: 42804041 [PubMed - indexed for MEDLINE]


Aetiology of positive surgical margins in robotic assisted radical prostatectomy: a pathway approach.
World J Urol
Day E, Bilé-Silva A, Bhudia A, Vigneshkumar A, Petkov G, Hakimnia K, Siddiqui F, Haider A, Dickinson L, Tandogdu Z.
PMID: 42803970 [PubMed - indexed for MEDLINE]


Biopsy and identification of risk factors for discordance in renal tumor: results from the BIRD study (UroCCR n°230).
World J Urol
Kutchukian S, Margue G, Branger N, Bigot P, Fontenil A, Boissier R, Prudhomme T, Michel C, Chatain V, Waeckel T, Beauval JB, Champy C, Vallée M, Lang H, de Vergie S, Vignot L, Parier B, Taha F, Surlemont L, Bernhard JC, Audenet F.
PMID: 42803961 [PubMed - indexed for MEDLINE]


Adoption of single-port robot-assisted radical prostatectomy following multiport xi experience: lessons from a learning curve analysis.
J Robot Surg
Son YM, Woo Ahn J, Kang DH, Chung DY.
PMID: 42803889 [PubMed - indexed for MEDLINE]


Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study).
Clin Transl Oncol
Fernández IP, Lorenzo VB, Dominguez RG, Gómez CI, Molina-Cerrillo J, Carbonero IG, Feliciangeli E, Ruiz SG, de Liaño AG, Valderrama BP, Sánchez ÁR, Morcuende RS, Rodríguez CS, Quintela MEL, Díaz EG, Padró JGI, Puente J, Guzman JCV, Sanchez JG, Kareaga MM, Zambrana MDCB, de Velasco G, Cabrero IR, García-Donas J, Munarriz J, Sarrió RG, Núñez NF, Gordoa TA, Esteban E.
PMID: 42803874 [PubMed - as supplied by publisher]


Early functional and oncological outcomes after robot-assisted radical prostatectomy in D'Amico high-risk prostate cancer: a prospective cohort study.
Arch Ital Urol Androl
Keller JM, Stankovic M, Wieder T, Wolff L, Mendes J.
PMID: 42803667 [PubMed - indexed for MEDLINE]


Let us trace our path from glass slide to virtual slide and artificial intelligence.
Arch Ital Urol Androl
Montironi R, Cimadamore A, Trinchieri A.
PMID: 42803663 [PubMed - indexed for MEDLINE]


Global trends and hotspots in bladder cancer: A bibliometric analysis (2016-2025).
Urologia
Heer R, Farrokhi M.
PMID: 42803329 [PubMed - as supplied by publisher]


Kidney impairment post 177Lu-PSMA radioligand therapy in metastatic prostate cancer.
Nucl Med Commun
Osbourne J, Hofman MS, Ruderman I.
PMID: 42802891 [PubMed - as supplied by publisher]


Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.
Eur J Nucl Med Mol Imaging
Mattana F, Luzzago S, Dragonetti V, Kasivisvanathan V, Conlon S, Castellucci P, Farolfi A, Miszczyk M, Techma, Rajwa P, Shariat SF, Zattoni F, Reitano G, Briganti A, Montorsi F, Frassoni S, Bagnardi V, Gandaglia G, Ceci F.
PMID: 42802268 [PubMed - as supplied by publisher]


Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation.
Prostate
Li L, Feng R, Zha B, Yang S, Wang G, Jiang Z, Mou J, Gao F.
PMID: 42801730 [PubMed - as supplied by publisher]


Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.
Prostate
Cilento MA, Lin HM, Yeung N, Kim RMN, Portman N, Stockler MR, Martin AJ, Subhash V, Yip S, Butler LM, Marschner IC, Meikle PJ, Azad AA, Davis ID, Horvath LG, Sweeney CJ.
PMID: 42801727 [PubMed - as supplied by publisher]


A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.
Mol Carcinog
Maroni P, Manalo TA, Baker H, Kessler ER, Nicklawsky A, Trevisanut V, Flaig TW, Lam ET, Moore JC, Gao D, Raina K, Agarwal R.
PMID: 42801665 [PubMed - as supplied by publisher]


Analysis of NAT2 coding variants, combined genotypes, and haplotypes in prostate cancer susceptibility: a case-control study in an Iraqi Arab population.
Mol Biol Rep
Tarish MA, Kudhair BK.
PMID: 42801388 [PubMed - indexed for MEDLINE]


Plasma circulating tumor deoxyribonucleic acid methylation enables noninvasive disease stratification beyond prostate-specific antigen in prostate cancer.
Prostate Int
Kim DW, Jung MH, Cho H, Cha J, Han KH, Choi JH, Park M, Park SH, Oh CK, Lee ST, Kim YJ, Chung JS.
PMID: 42801146 [PubMed]


   
   Artikel 1 - 20 / 181776    Seite 1 von 9089  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1